GENE ONLINE|News &
Opinion
Blog

Companion Diagnostic
FDA Approves Foundation Medicine’s Liquid Biopsy Test as Companion Diagnostic for Novartis’ Tabrecta
2021-07-18
FoundationOne CDx Okayed as Companion Diagnostic for Takeda’s Lung Cancer Drug
2021-07-04
FDA Okays Second FGFR Inhibitor for Cholangiocarcinoma, Approves FMI’s CGP Test as Companion Diagnostic
2021-05-31
10 Precision Oncology Companies to Look Out for
2021-05-27
R&D
Mirvie Heralds Liquid Biopsy-Based Test to Predict Pregnancy Complications
2021-04-28
FMI’s Liquid Biopsy Test Adds 3 Companion Diagnostic Indications for Advanced Ovarian, Breast and Lung Cancers
2020-10-30
FDA Okays Foundation Medicine’s Comprehensive Liquid Biopsy Test
2020-08-27
Weekly in Asia|Oct-1
2019-10-14
Weekly in Asia 20190602-0608
2019-06-11
A competition for cancer cells and human medical testing – How to use liquid biopsy to break through the testing dilemma?
2018-10-11
Latest Developments in Precision Medicine and Molecular Detection
2018-09-19
“Project Oxygen”of Precision Medicine Exclusive Interview of Dr. Chris Tsai, Founder of Bionet
2017-08-07
LATEST
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Singapore’s NUS Medicine Launches Centre for Sustainable Medicine
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top